Literature DB >> 191824

Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.

J E Robinson, W A Andiman, E Henderson, G Miller.   

Abstract

In an attempt to account for differences in the biologic behavior of Epstein-Barr virus in different primate species, we studied lymphocyte surface markers on primary and transformed cells. Among primary leukocytes, the distribution of cells with characteristics of bone-marrow-derived cells (B cells) was similar in humans, wooly monkeys, and cotton-top marmosets. However, after transformation by Epstein-Barr virus, cells from each species were characterically different. Transformed human umbilical cord cells expressed the complement receptor; monkey cells exhibited both this receptor and the receptor for IgG Fc (EA7S); and marmoset cells did not have either surface marker. We measured the transformation efficiency of human and marmoset leukocyte subpopulations enriched or depeleted in cells with the complement receptor. In both species the highest efficiencies of transformation were found in populations with the greatest numbers of cells with the receptor. The data therefore suggest that, in all species, a cell with the complement receptor is susceptible to transformation but that this receptor is not expressed on transformed marmoset cells. Thus, in Epstein-Barr virus-induced transformation it is necessary to distinguish between transformation of growth properties (immortalization) and transformation of cell surface properties.

Entities:  

Mesh:

Year:  1977        PMID: 191824      PMCID: PMC392371          DOI: 10.1073/pnas.74.2.749

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Immunoglobulin-bearing and complement-receptor lymphocytes constitute the same population in human peripheral blood.

Authors:  A G Ehlenberger; M McWilliams; J M Phillips-Quagliata; M E Lamm; V Nussenzweig
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

2.  Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.

Authors:  M F Greaves; G Brown
Journal:  Clin Immunol Immunopathol       Date:  1975-03

3.  Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

Authors:  A L Epstein; W Henle; G Henle; J F Hewetson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

Review 4.  Epstein-Barr virus and nonhuman primates: natural and experimental infection.

Authors:  A Frank; W A Andiman; G Miller
Journal:  Adv Cancer Res       Date:  1976       Impact factor: 6.242

5.  Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines.

Authors:  E Yefenof; G Klein; M Jondal; M B Oldstone
Journal:  Int J Cancer       Date:  1976-06-15       Impact factor: 7.396

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.

Authors:  G Miller; D Coope; J Niederman; J Pagano
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

8.  Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.

Authors:  J Menezes; M Jondal; W Leibold; G Dorval
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

9.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

10.  Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus.

Authors:  T Shope; D Dechairo; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

View more
  5 in total

1.  Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.

Authors:  J Robinson; A Frank; E Henderson; J Schweitzer; G Miller
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Radiobiological inactivation of Epstein-Barr virus.

Authors:  E Henderson; L Heston; E Grogan; G Miller
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

3.  Effects of nucleoside analogs on Epstein-Barr virus-induced transformation of human umbilical cord leukocytes and Epstein-Barr virus expression in transformed cells.

Authors:  E E Henderson; W K Long; R Ribecky
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 4.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

5.  Epstein-Barr virus in cerebrospinal fluid during infectious mononucleosis encephalitis.

Authors:  J A Schiff; J A Schaefer; J E Robinson
Journal:  Yale J Biol Med       Date:  1982 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.